within Pharmacolibrary.Drugs.ATC.M;

model M02AA11
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 1.9999999999999998e-05,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.02,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M02AA11</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Bendazac is a non-steroidal anti-inflammatory drug (NSAID), structurally related to fenamates, with uses primarily in the treatment of inflammatory conditions such as arthritis and as an agent to slow cataract formation. It is rarely used today and is not widely approved; its main historical use was for topical or ocular disorders.</p><h4>Pharmacokinetics</h4><p>No published human pharmacokinetic studies or models for bendazac were found in the indexed literature. No explicitly reported pharmacokinetic values are available.</p><h4>References</h4><ol><li><p>Rovei, V, et al., &amp; Houin, G (1987). Pharmacokinetics of bendazac-lysine and 5-hydroxybendazac in patients with renal insufficiency. <i>European journal of clinical pharmacology</i> 33(3) 303–310. DOI:<a href=&quot;https://doi.org/10.1007/BF00637567&quot;>10.1007/BF00637567</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3691618/&quot;>https://pubmed.ncbi.nlm.nih.gov/3691618</a></p></li><li><p>Rovei, V, et al., &amp; Houin, G (1988). The pharmacokinetics of bendazac-lysine and 5-hydroxybendazac, its main metabolite, in patients with hepatic cirrhosis. <i>European journal of clinical pharmacology</i> 35(4) 391–396. DOI:<a href=&quot;https://doi.org/10.1007/BF00561370&quot;>10.1007/BF00561370</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3197747/&quot;>https://pubmed.ncbi.nlm.nih.gov/3197747</a></p></li><li><p>Chen, XX, et al., &amp; Qiu, JJ (1997). Pharmacokinetics of bendazac lysine in 10 Chinese young men. <i>Zhongguo yao li xue bao = Acta pharmacologica Sinica</i> 18(2) 109–111. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10072958/&quot;>https://pubmed.ncbi.nlm.nih.gov/10072958</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M02AA11;
